Opko Health (OPK) Cash from Financing Activities (2010 - 2026)

Opko Health (OPK) has 17 years of Cash from Financing Activities data on file, last reported at -$13.0 million in Q2 2026.

• Quarterly Cash from Financing Activities rose 83.61% year-over-year to -$13.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$52.7 million (down 133.03% YoY) and the FY2025 annual result came in at -$118.1 million, down 164.1% from the prior year.
• Cash from Financing Activities retreated to -$13.0 million in Q2 2026, from -$5.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $224.6 million in Q3 2024 to a low of -$79.5 million in Q2 2025.
• A 5-year average of $8.2 million and a median of -$3.8 million in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 10571.64% — and 2025, when it sank 529.72%.
• Tracing OPK's Cash from Financing Activities over 5 years: stood at $10.1 million in 2022, then sank by 136.98% to -$3.8 million in 2023, then soared by 6088.75% to $224.6 million in 2024, then plunged by 108.16% to -$18.3 million in 2025, then increased by 28.97% to -$13.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$13.0 million (Q2 2026), -$5.2 million (Q1 2026), and -$18.3 million (Q4 2025), per Business Quant data.